These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3147926)

  • 1. Fibrinolytic properties of peritoneal fluid in endometriosis.
    Dunselman GA; Bouckaert PX; van Wersch JW; Brommer EJ; Evers JL
    Gynecol Obstet Invest; 1988; 26(4):302-7. PubMed ID: 3147926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravascular and peritoneal coagulation and fibrinolysis in horses with acute gastrointestinal tract diseases.
    Collatos C; Barton MH; Prasse KW; Moore JN
    J Am Vet Med Assoc; 1995 Aug; 207(4):465-70. PubMed ID: 7591947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clotting and fibrinolytic activities in peritoneal fluid.
    Pattinson HA; Koninckx PR; Brosens IA; Vermylen J
    Br J Obstet Gynaecol; 1981 Feb; 88(2):160-6. PubMed ID: 6779852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for the fibrinolytic system in postsurgical adhesion formation.
    Hellebrekers BW; Emeis JJ; Kooistra T; Trimbos JB; Moore NR; Zwinderman KH; Trimbos-Kemper TC
    Fertil Steril; 2005 Jan; 83(1):122-9. PubMed ID: 15652897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneal fluid and plasma fibrinolytic activity in women with pelvic inflammatory disease.
    Dörr PJ; Brommer EJ; Dooijewaard G; Vemer HM
    Thromb Haemost; 1992 Aug; 68(2):102-5. PubMed ID: 1412151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinolysis in the peritoneal fluid during adhesions, endometriosis and ongoing pelvic inflammatory disease.
    Edelstam G; Lecander I; Larsson B; Astedt B
    Inflammation; 1998 Aug; 22(4):341-51. PubMed ID: 9675606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal D-dimer concentration for assessing peritoneal fibrinolytic activity in horses with colic.
    Delgado MA; Monreal L; Armengou L; Ríos J; Segura D
    J Vet Intern Med; 2009; 23(4):882-9. PubMed ID: 19566853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal fibrinolytic activity and adhesiogenesis.
    Fometescu SG; Costache M; Coveney A; Oprescu SM; Serban D; Savlovschi C
    Chirurgia (Bucur); 2013; 108(3):331-40. PubMed ID: 23790781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
    Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrinolytic capacity in peritoneal fluid after laparoscopic and conventional colorectal resection: data from a randomized controlled trial.
    Neudecker J; Junghans T; Raue W; Ziemer S; Schwenk W
    Langenbecks Arch Surg; 2005 Nov; 390(6):523-7. PubMed ID: 16155766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
    Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
    Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of fibrinolysis and their application to fibrin-specific thrombolytic therapy.
    Collen D
    J Cell Biochem; 1987 Feb; 33(2):77-86. PubMed ID: 3553213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-thrombolysis haemostasis changes after rt-PA treatment in acute cerebral infarct. Correlations with cardioembolic aetiology and outcome.
    Sun X; Berthiller J; Derex L; Trouillas P; Diallo L; Hanss M
    J Neurol Sci; 2015 Feb; 349(1-2):77-83. PubMed ID: 25619569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrin-specific thrombolytic agents.
    Collen D
    Klin Wochenschr; 1988; 66 Suppl 12():15-23. PubMed ID: 3126344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parameters of fibrinolysis in peritoneal fluid and plasma in different stages of the menstrual cycle.
    Dörr PJ; Brommer EJ; Dooijewaard G; Vemer HM
    Thromb Haemost; 1993 Nov; 70(5):873-5. PubMed ID: 8128449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Parameters related to fibrinolysis and their meanings].
    Urano T; Suzuki Y
    Rinsho Byori; 2011 Jul; 59(7):703-8. PubMed ID: 21874797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of intraperitoneal and intravascular coagulation and fibrinolysis related antigens in peritoneal dialysis.
    Gries E; Kopp J; Thomae U; Kuhlmann H
    Thromb Haemost; 1990 Jun; 63(3):356-60. PubMed ID: 2205948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assays.
    Camiolo SM; Greco WR
    Cancer Res; 1986 Apr; 46(4 Pt 1):1788-94. PubMed ID: 3081257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.